share_log

免疫生物研究所---大幅に反発、消化管間質腫瘍を診断・治療する抗体医薬品の特許を徳島大と共同で取得

Institute for Immunobiology --- Significant backlash; joint acquisition of a patent for an antibody drug to diagnose and treat gastrointestinal stromal tumors with Tokushima University

Fisco Japan ·  Apr 4 20:56

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

Login or create a forever free account to read this news
Sign up/Log in
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment